TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$14.25 USD
+0.51 (3.71%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $14.26 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/6/24 |
---|---|
Current Quarter | -0.03 |
EPS Last Quarter | -0.09 |
Last EPS Surprise | 25.00% |
ABR | 1.63 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.12 |
Next Year | 0.57 |
EPS (TTM) | 0.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 54.92M | 56.69M | 254.80M | 415.23M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 58.62M | 59.40M | 274.40M | 540.30M |
Low Estimate | 46.00M | 52.11M | 239.76M | 326.92M |
Year ago Sales | 7.80M | 16.07M | 233.66M | 254.80M |
Year over Year Growth Est. | 604.04% | 252.78% | 9.05% | 62.96% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.03 | -0.05 | -0.12 | 0.57 |
# of Estimates | 4 | 4 | 7 | 5 |
Most Recent Consensus | -0.02 | -0.06 | -0.34 | 0.93 |
High Estimate | 0.00 | -0.01 | 0.18 | 0.93 |
Low Estimate | -0.07 | -0.08 | -0.53 | 0.19 |
Year ago EPS | -0.28 | -0.34 | 0.09 | -0.12 |
Year over Year Growth Est. | 89.29% | 85.29% | -233.33% | 575.95% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.03 | -0.05 | -0.12 | 0.57 |
7 Days Ago | -0.03 | -0.05 | -0.12 | 0.57 |
30 Days Ago | -0.03 | -0.05 | -0.12 | 0.58 |
60 Days Ago | -0.09 | -0.06 | -0.10 | 0.65 |
90 Days Ago | -0.10 | -0.05 | -0.09 | 0.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.03 | -0.05 | -0.12 | 0.68 |
Zacks Consensus Estimate | -0.03 | -0.05 | -0.12 | 0.57 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 18.47% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.09 | 0.73 | -0.34 | -0.28 | NA |
Estimate | -0.12 | 0.29 | -0.26 | -0.36 | NA |
Difference | 0.03 | 0.44 | -0.08 | 0.08 | 0.12 |
Surprise | 25.00% | 151.72% | -30.77% | 22.22% | 42.04% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more